These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 23986394)

  • 21. Radiologic Improvement of juvenile idiopathic arthritis-enthesitis-related arthritis following anti-tumor necrosis factor-alpha blockade with etanercept.
    Tse SM; Laxer RM; Babyn PS; Doria AS
    J Rheumatol; 2006 Jun; 33(6):1186-8. PubMed ID: 16755667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Biological therapy with TNF-inhibitors in pediatric rheumatology. Review of the literature and personal experience].
    Gerloni V; Pontikaki I; Gattinara M; Fantini F
    Reumatismo; 2007; 59(3):244-61. PubMed ID: 17898886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Skin manifestations induced by TNF-alpha inhibitors in juvenile idiopathic arthritis.
    Pontikaki I; Shahi E; Frasin LA; Gianotti R; Gelmetti C; Gerloni V; Meroni PL
    Clin Rev Allergy Immunol; 2012 Apr; 42(2):131-4. PubMed ID: 21403999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Switching the therapy from etanercept to infliximab in a child with rheumatoid factor positive polyarticular juvenile idiopathic arthritis.
    Nerome Y; Imanaka H; Nonaka Y; Takei S
    Mod Rheumatol; 2007; 17(6):526-8. PubMed ID: 18084710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Malignancy and tumor necrosis factor inhibitors in juvenile idiopathic arthritis].
    Horneff G
    Z Rheumatol; 2010 Aug; 69(6):516-26. PubMed ID: 20532787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of safety profiles of tumour necrosis factor α inhibitors and rituximab therapy in patients with rheumatoid arthritis and chronic hepatitis C.
    Chen YM; Chen HH; Chen YH; Hsieh TY; Hsieh CW; Hung WT; Lan JL; Chen DY
    Ann Rheum Dis; 2015 Mar; 74(3):626-7. PubMed ID: 25452310
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical remission in patients with systemic juvenile idiopathic arthritis treated with anti-tumor necrosis factor agents.
    Russo RA; Katsicas MM
    J Rheumatol; 2009 May; 36(5):1078-82. PubMed ID: 19435972
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trials reveal promising options for treating juvenile rheumatoid arthritis.
    Hampton T
    JAMA; 2008 Jan; 299(1):27-8. PubMed ID: 18167400
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment choices of paediatric rheumatologists for juvenile idiopathic arthritis: etanercept or adalimumab?
    Anink J; Otten MH; Gorter SL; Prince FH; van Rossum MA; van den Berg JM; van Pelt PA; Kamphuis S; Brinkman DM; Swen WA; Swart JF; Wulffraat NM; Dolman KM; Koopman-Keemink Y; Hoppenreijs EP; Armbrust W; ten Cate R; van Suijlekom-Smit LW
    Rheumatology (Oxford); 2013 Sep; 52(9):1674-9. PubMed ID: 23740187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of refractory tumor necrosis factor inhibitor-induced palmoplantar pustulosis: a report of 2 cases.
    Chu DH; Van Voorhees AS; Rosenbach M
    Arch Dermatol; 2011 Oct; 147(10):1228-30. PubMed ID: 22006150
    [No Abstract]   [Full Text] [Related]  

  • 31. Baseline anti-dsDNA concentrations and previous treatments predict response to Adalimumab and Etanercept: a retrospective investigation of 146 psoriasis patients.
    Hoffmann JH; Knoop C; Enk AH; Hadaschik EN
    J Dermatol Sci; 2014 Dec; 76(3):180-5. PubMed ID: 25306295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of adverse effect of anti-tumor necrosis factor-α biologics in treatment of rheumatoid arthritis: 5 years follow-up.
    Dewedar AM; Shalaby MA; Al-Homaid S; Mahfouz AM; Shams OA; Fathy A
    Int J Rheum Dis; 2012 Jun; 15(3):330-5. PubMed ID: 22709496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-tumor necrosis factor therapy: 6 year experience of a single center in northern Israel and possible impact of health policy on results.
    Braun-Moscovici Y; Markovits D; Rozin A; Toledano K; Nahir AM; Balbir-Gurman A
    Isr Med Assoc J; 2008 Apr; 10(4):277-81. PubMed ID: 18548981
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of juvenile idiopathic arthritis in the biologic age.
    Stoll ML; Cron RQ
    Rheum Dis Clin North Am; 2013 Nov; 39(4):751-66. PubMed ID: 24182853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful use of antitumor necrosis factor-alpha biological therapy in managing human immunodeficiency virus-associated arthritis: three case studies from Saudi Arabia.
    Almoallim H; Jali I; Wali G
    Joint Bone Spine; 2013 Jul; 80(4):426-8. PubMed ID: 23453475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adalimumab-Induced Cutaneous Lupus Erythematosus in a 16-Year-Old Girl with Juvenile Idiopathic Arthritis.
    West ES; Nanda K; Ofodile O; Rutledge J; Brandling-Bennett HA
    Pediatr Dermatol; 2015; 32(4):e140-4. PubMed ID: 25845414
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Granuloma annulare induced by anti-tumour necrosis factor therapy.
    Voulgari PV; Markatseli TE; Exarchou SA; Zioga A; Drosos AA
    Ann Rheum Dis; 2008 Apr; 67(4):567-70. PubMed ID: 17728330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone status in adults with early-onset juvenile idiopathic arthritis following 1-year anti-TNFα therapy and discontinuation of glucocorticoids.
    Brabnikova Maresova K; Jarosova K; Pavelka K; Stepan JJ
    Rheumatol Int; 2013 Aug; 33(8):2001-7. PubMed ID: 23370856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Broad range of adverse cutaneous eruptions in patients on TNF-alpha antagonists.
    Hawryluk EB; Linskey KR; Duncan LM; Nazarian RM
    J Cutan Pathol; 2012 May; 39(5):481-92. PubMed ID: 22515220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-tumour necrosis factor therapy associated with cutaneous vasculitis.
    Livermore PA; Murray KJ
    Rheumatology (Oxford); 2002 Dec; 41(12):1450-2. PubMed ID: 12468829
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.